MedTrace Logo

Autologous Cord Blood Cells for Brain Injury in Term Newborns

NCT01649648 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2017-01-26

No results posted yet for this study

Summary

This is a pilot study to test feasibility and safety of collection, preparation and infusion of a baby's own (autologous) umbilical cord blood during the first 3 days of age if the baby is born with signs of brain injury. The cord blood used is fresh (not frozen and then thawed).

Conditions

  • Hypoxic Ischemic Encephalopathy

Interventions

BIOLOGICAL

Autologous cord blood

Baby's own umbilical cord blood

Sponsors & Collaborators

  • National Medical Research Council (NMRC), Singapore

    collaborator OTHER_GOV

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Jiun Lee, MBBS · National University Hospital, Singapore

  • Samuel Rajadurai, MBBS · KK Women's and Children's Hospital

  • Cheo Lian Yeo, MBBS · Singapore General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
3 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-11-30
Completion
2015-11-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01649648 on ClinicalTrials.gov